Pancragen 20 mg

Pancragen is a short tetrapeptide bioregulator that targets pancreatic tissue, part of the well-known Khavinson family of peptide bioregulators. It is best known in research for studying how very small peptide sequences interact with pancreatic cell models, and its compact, tissue-specific design is what makes it stand out.

It also sits on an established research base, with work exploring short peptides and glucose-regulation systems in the lab (Khavinson & Anisimov, 2009). That track record is why it often turns up as a reference compound in this kind of study.

Research Applications

• Pancreatic cell-model research
• Peptide bioregulator studies
• Glucose-regulation research systems
• Tissue-specific peptide signaling

Supplied as a lyophilized powder for stability.

See also: Cardiogen 20 mg, Ovagen 20 mg, and Livagen 20 mg.

$21

Pancragen 20 mg Structure

Peptide Class: Short peptide bioregulator (Khavinson-school)
Amino Acid Sequence: Sequence available on request
Molecular Formula: C₂₆H₃₆N₆O₉
Molecular Weight: See product data
CAS Number: N/A

$22

$23